A novel role for signal transducer and activator of transcription 5b (STAT5b) in β1-integrin-mediated human breast cancer cell migration

Breast Cancer Research

Volumn 11, Issue 4, 2009, Pages

  Bernaciak, Teresa M ^a,c   Zareno, Jessica ^b   Parsons, J Thomas ^a,c   Silva, Corinne M ^a,b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5B; SMALL INTERFERING RNA; STAT PROTEIN; UNCLASSIFIED DRUG; STAT5 PROTEIN; STAT5B PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; BREAST CANCER; CELL MIGRATION; CELL MOTILITY; CELL SPREADING; CELL STRUCTURE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; PROTEIN FUNCTION; WOUND HEALING; BREAST TUMOR; CANCER INVASION; CELL MOTION; CHEMISTRY; DRUG EFFECT; FEMALE; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SRC HOMOLOGY DOMAIN; TUMOR CELL LINE;

ANTIGENS, CD29; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; FIBRONECTINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SRC HOMOLOGY DOMAINS; STAT5 TRANSCRIPTION FACTOR; WOUND HEALING;

EID: 77449143515     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2341     Document Type: Article

References (29)

1. Darnell JE. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002, 2:740-749. 10.1038/nrc906, 12360277.
2. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000, 19:2474-2488. 10.1038/sj.onc.1203527, 10851046.
3. Turkson J, Jove R. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 2000, 19:6613-6626. 10.1038/sj.onc.1204086, 11426647.
4. Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG, Kanakura Y. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J 1999, 18:1367-1377. 10.1093/emboj/18.5.1367, 1171226, 10064602.
5. de Groot RP, Raaijmakers JA, Lammers JW, Koenderman L. STAT5-dependent cyclin D1 and Bcl-xL expression in Bcr-Abl-transformed cells. Mol Cell Biol Res Commun 2000, 3:299-305. 10.1006/mcbr.2000.0231, 10964754.
6. Silva M, Benito A, Sanz C, Prosper F, Ekhterae D, Nunez G, Fernandez-Luna JL. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 1999, 274:22165-22169. 10.1074/jbc.274.32.22165, 10428780.
7. Horita M, Andreu EJ, Benito A, Arbona C, Sanz C, Benet I, Prosper F, Fernandez-Luna JL. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J Exp Med 2000, 191:977-984. 10.1084/jem.191.6.977, 2193112, 10727459.
8. Nieborowska-Skorska M, Hoser G, Kossev P, Wasik MA, Skorski T. Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood 2002, 99:4531-4539. 10.1182/blood.V99.12.4531, 12036885.
9. Kazansky AV, Spencer DM, Greenberg NM. Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system. Cancer Res 2003, 63:8757-8762.
10. Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 2005, 24:746-760. 10.1038/sj.onc.1208203, 15592524.
11. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 1997, 11:179-186. 10.1101/gad.11.2.179, 9009201.
12. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 1997, 94:7239-7244. 10.1073/pnas.94.14.7239, 23803, 9207075.
13. Kloth MT, Catling AD, Silva CM. Novel activation of STAT5b in response to epidermal growth factor. J Biol Chem 2002, 277:8693-8701. 10.1074/jbc.M111884200, 11751923.
14. Kloth MT, Laughlin KK, Biscardi JS, Boerner JL, Parsons SJ, Silva CM. STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor. J Biol Chem 2003, 278:1671-1679. 10.1074/jbc.M207289200, 12429742.
15. Riggins RB, Thomas KS, Ta HQ, Wen J, Davis RJ, Schuh NR, Donelan SS, Owen KA, Gibson MA, Shupnik MA, Silva CM, Parsons SJ, Clarke R, Bouton AH. Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer Res 2006, 66:7007-7015. 10.1158/0008-5472.CAN-05-3952, 16849545.
16. Weaver AM, Silva CM. Modulation of signal transducer and activator of transcription 5b activity in breast cancer cells by mutation of tyrosines within the transactivation domain. Mol Endocrinol 2006, 20:2392-2405. 10.1210/me.2005-0418, 16772534.
17. Fox EM, Bernaciak TM, Wen J, Weaver AM, Shupnik MA, Silva CM. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Mol Endocrinol 2008, 22:1781-1796. 10.1210/me.2007-0419, 2505329, 18550772.
18. Yamashita H, Iwase H, Toyama T, Fujii Y. Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells. Oncogene 2003, 22:1638-1652. 10.1038/sj.onc.1206277, 12642867.
19. Yamashita H, Nishio M, Fujii Y, Iwase H. Dominant-negative stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude mice. Cancer Sci 2004, 95:662-665. 10.1111/j.1349-7006.2004.tb03326.x, 15298729.
20. Weaver AM, Silva CM. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6. Breast Cancer Res 2007, 9:R79. 10.1186/bcr1794, 2246177, 17997837.
21. Li X, Leung S, Kerr IM, Stark GR. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol Cell Biol 1997, 17:2048-2056. 232052, 9121453.
22. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verategui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56. 10.1038/35065016, 11242036.
23. Hayman EG, Ruoslahti E. Distribution of fetal bovine serum fibronectin and endogenous rat fibronectin in extracellular matrix. J Cell Biol 1979, 83:255-259. 10.1083/jcb.83.1.255, 2110434, 389940.
24. Xi S, Zhang Q, Gooding WE, Smithgall TE, Grandis JR. Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Cancer Res 2003, 63:6763-6771.
25. Kazansky AV, Rosen JM. Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells. Cell Growth Differ 2001, 12:1-7.
26. Ng DC, Lin BH, Lim CP, Huang G, Zhang T, Poli V, Cao X. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol 2006, 172:245-257. 10.1083/jcb.200503021, 2063554, 16401721.
27. Mao X, Ren Z, Parker GN, Sondermann H, Pastorello MA, Wang W, McMurray JS, Demeler B, Darnell JEJ, Chen X. Structural bases of unphosphorylated STAT1 association and receptor binding. Mol Cell 2005, 17:761-771. 10.1016/j.molcel.2005.02.021, 15780933.
28. Neculai D, Neculai AM, Verrier S, Straub K, Klumpp K, Pfitzner E, Becker S. Structure of the unphosphorylated STAT5a dimer. J Biol Chem 2005, 280:40782-40787. 10.1074/jbc.M507682200, 16192273.
29. Burridge K, Doughman R. Front and back by Rho and Rac. Nature Cell Biol 2006, 8:781-782. 10.1038/ncb0806-781, 16880807.